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Accuracy of mobility tests for screening the risk of 
falls in patients with mild cognitive impairment and 
alzheimer’s disease
Acurácia de testes de mobilidade para o rastreio do risco de quedas no comprometimento 
cognitivo leve e doença de Alzheimer
Exactitud de las pruebas de movilidad para detectar riesgo de caídas en el deterioro cognitivo 
leve y en la enfermedad de Alzheimer
Juliana Hotta Ansai1, Verena Vassimon-Barroso2, Ana Claudia Silva Farche3,  
Marcele Stephanie de Souza Buto4, Larissa Pires de Andrade5, José Rubens Rebelatto6
ABSTRACT | Identifying gait and balance disorders in 
the earlier stages of Alzheimer’s disease (AD) and Mild 
Cognitive Impairment (MCI) could reduce or prevent 
falls in older adults. This cross-sectional study aimed 
to determine which mobility tests best discriminate the 
risk of falls in MCI and mild AD. Functional mobility was 
assessed by the timed up and go test (TUG) and 10-meter 
walk test (10MWT). A calendar of falls was produced, 
with follow-up via telephone calls during 6 months. For 
the MCI Group (n=38), time spent on the 10MWT was the 
best variable for discriminating fallers, with a cut-off point 
of 10.69 seconds associated with the highest accuracy 
(76.3%). In the AD Group (n=37), 10MWT cadence was the 
best variable for discriminating fallers, with a cut-off point 
of 101.39 steps per minute associated with an accuracy 
of 81.1%. As a conclusion, 10MWT time and cadence were 
the most accurate variables for screening the risk of 
falls in MCI and mild AD, respectively. The 10MWT is a 
functional, simple and easy test and it should be widely 
used in clinical practice.
Keywords | Falls; Cognition; Aged.
RESUMO | A identificação de distúrbios da marcha e do 
equilíbrio em estágios iniciais da doença de Alzheimer (DA) 
e do comprometimento cognitivo leve (CCL) pode reduzir 
ou prevenir quedas na população idosa. Transversal, este 
estudo tem como objetivo determinar quais testes de 
mobilidade melhor discriminam o risco de quedas em 
idosos com CCL e DA leve. A mobilidade funcional foi 
avaliada pelo timed up and go test (TUG) e o teste de 
velocidade de marcha de 10 metros (10MWT). Foi produzido 
um calendário de quedas, com acompanhamento via 
contato telefônico durante 6 meses. Para o grupo CCL 
(n=38), o tempo gasto no 10MWT foi a melhor variável 
para discriminar caidores, com nota de corte de 10,69 
segundos associada a maior precisão (76,3%). No grupo 
DA (n=37), a cadência do 10MWT foi a melhor variável 
para discriminar os caidores, com nota de corte de 101,39 
passos por minuto associada a uma precisão de 81,1%. 
Como conclusão, o tempo e a cadência do 10MWT foram 
as variáveis mais precisas para rastrear o risco de quedas 
em idosos com CCL e DA leve, respectivamente. O 10MWT 
é um teste funcional, simples e fácil e pode ser amplamente 
utilizado na prática clínica.
Descritores | Quedas; Cognição; Idosos.
RESUMEN | La identificación de los trastornos de marcha 
y del equilibrio en las primeras etapas de la enfermedad 
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de Alzheimer (EA) y del deterioro cognitivo leve (DCL) puede 
reducir o prevenir las caídas en la población anciana. Estudio 
transversal que tiene como objetivo determinar qué pruebas de 
movilidad discriminan mejor el riesgo de caídas en los ancianos 
con DCL y EA leve. La movilidad funcional se evaluó mediante el 
timed up and go test (TUG) y la prueba de velocidad de marcha 
de 10 metros (10MWT). Se elaboró un calendario de caídas, 
con seguimiento vía contacto telefónico durante 6 meses. En 
el grupo DCL (n=38), el tiempo empleado en el 10MWT fue la 
mejor variable para discriminar las caídas, con un puntaje de 
corte de 10,69 segundos asociado a una mayor precisión (76,3%). 
En el grupo de EA (n=37), la cadencia de 10MWT fue la mejor 
variable para discriminar las caídas, con un puntaje de corte 
de 101,39 pasos por minuto asociada a una precisión del 81,1%. 
Se concluye que el tiempo y la cadencia de 10MWT fueron las 
variables más precisas para detectar el riesgo de caídas en los 
ancianos con DCL y EA leve, respectivamente. El 10MWT es una 
prueba funcional, simple y fácil, y se puede utilizarla ampliamente 
en la práctica clínica.
Palabras clave | Caídas; Cognición; Anciano. 
INTRODUCTION
Older people with cognitive impairment, such as mild 
cognitive impairment (MCI) and Alzheimer’s disease 
(AD), are at increased risk of falls, with prevalence 
of falls up to 60%1. In this sense, fall assessment and 
strategies for reducing or preventing falls are essential 
to avoid adverse outcomes, such as fractures, injuries 
and functional damage2. Falls are a serious public health 
problem, thus, earlier identification of potential fallers 
in this population is needed.
Gait and balance disorders may be identified even in 
earlier stages of AD and MCI3,4. These impairments have 
been reported as important contributors to the increased 
risk of falls in older adults with cognitive impairment5. The 
updated American/British Geriatrics Society guidelines for 
prevention of falls recommend that gait and balance deficits 
should be assessed in older individuals reporting a single 
fall and used as a screen for identifying individuals who 
may benefit from a multifactorial risk of fall assessment6.
Among several functional mobility tools, walk tests and 
the timed up and go test (TUG) are widely used in clinical 
practice. The 10-meter walk test (10MWT) has been used 
as an important predictor of functional capacity7 and as a 
predictor of multiple falls in community-dwelling older 
people, using a cut-off point around 6 seconds8. On the 
other hand, the TUG test is fast and easy to apply, and it 
was validated for screening risk of falls, with a cut-off point 
around 12 seconds in Brazilian older community people9.
Differences in mobility performance were found 
between fallers and non-fallers with cognitive impairment5, 
however, the separate analysis of people with MCI and AD 
in mild phase remains scarce. Knowing that prevalence and 
history of falls differ according to the cognitive impairment, 
type and phase of dementia10,11, analyzing the accuracy of 
functional mobility tests for screening risk of falls among 
MCI and mild AD is necessary to improve screening 
and prevention of falls in these populations. Therefore, 
the purpose of this study was to determine which of the 
two commonly used functional mobility tools (TUG and 
10MWT) best discriminated risk of falls in Brazilian older 
community people with MCI and mild AD.
METHODOLOGY
Participants
Recruitment and prospective data collection were 
conducted between 2015 and 2016. Inclusion criteria were the 
ability to walk at least 10 meters alone without a walking aid 
and the availability to participate in the proposed assessments. 
Exclusion criteria were the presence of motor alterations after 
a stroke, other types of dementia, neurological disorders that 
interfered in cognition or mobility, severe uncorrected visual 
or auditory disorders and advanced or moderate AD. An 
experienced neurologist professor confirmed the diagnosis 
of MCI and AD (mild stage) and the details of diagnosis 
criteria have been described in a previous study12.
Procedures
After written informed consent was obtained and 
before the assessments, the volunteers were instructed 
to wear comfortable clothing and closed usual shoes, to 
have eaten at least one hour prior to the assessments, to 
have avoided vigorous exercise the day before and to bring 
visual or auditory aids, if necessary. All assessments were 
conducted by the same two trained physical therapists in 
a closed environment.
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A structured questionnaire was administered and 
the following socio-demographic and clinical data were 
collected: age, sex, body mass index, educational level, 
number of comorbidities, use of psychotropic drugs, 
previous falls in the last year and level of physical activity 
(Minnesota Questionnaire) (kcal/week)13. The answers of 
the volunteers with MCI were confirmed by an informant, 
i.e., a person who stayed with the older adult at least half 
a day, four times per week. Both the volunteer with AD 
and his informant answered the questionnaire.
Functional mobility
Functional mobility was determined by the 10MWT 
and the TUG test. During the 10MWT, the volunteers 
were instructed to begin walking 1.2m before the 
beginning of the course and to finish 1.2m after the 
end of the course at usual speed in order to eliminate 
acceleration and deceleration components14. The test was 
conducted once, and time, number of steps and cadence 
were recorded for further analysis. 
During the TUG test, the individual was instructed 
to stand up from a seated position (in a chair 45-cm 
high with trunk support and armrests), walk 3m, turn 
around, walk back to the chair and sit down15. The TUG 
test was performed two times (1 familiarization and 1 
test trial). Specific paused instructions of the test have 
been described in a previous study12. Time, number of 
steps and cadence were marked. Both mobility tests were 
performed without a walking aid.
Falls follow-up
Participants were followed up for six months. Each 
volunteer or informant received a calendar of falls and 
monthly telephone calls in order to ensure accurate data 
collection. The definition of fall was “an event which 
results in a person coming to rest inadvertently on the 
ground or floor or other lower level and other than as a 
consequence of the following: sustaining a violent blow; 
loss of consciousness; sudden onset of paralysis; or an 
epileptic seizure”16. Each group (MCI and AD) was 
subdivided in faller and non-faller. A faller was considered 
a person who fell at least once during the follow-up.
Statistical analysis
A significance level of 5% was adopted and the SPSS 
software (20.0) was used. Data normality was tested by 
the Kolmogorov-Smirnov test. The Student’s t-test and 
the Chi-square test were used to compare quantitative and 
categorical data between fallers and non-fallers in each 
group (MCI and AD). Receiver operating characteristic 
(ROC) curves were used to determine the cut-off score 
that maximized sensitivity and specificity for each mobility 
test. Sensitivity describes the proportion of fallers who 
were correctly identified by the test as having risk of fall. 
Specificity describes the proportion of non-fallers who 
were correctly identified by the test as not having risk of 
fall. Accuracy was calculated as the total number of true 
positives and negatives divided by the total number of 
true and false positives and negatives17.
RESULTS
At baseline, 40 older people with MCI and 38 with 
mild AD were assessed. However, two women with MCI 
and one woman with AD died during follow-up and 
therefore their data were not analyzed. The prospective 
analysis was based on the performance of 38 people with 
MCI (20 fallers and 18 non-fallers) and 37 people with 
mild AD (19 fallers and 18 non-fallers). There were no 
differences at baseline between fallers and non-fallers of 
both MCI and AD groups, except in previous fall data. 
In the MCI Group, the faller subgroup showed more 
prevalence of previous falls (80%) than the non-faller 
one (p<0.01) (Table 1). 
Table 1. Baseline characteristics between fallers and non-fallers identified over the 6-month follow-up
Characteristics, M (SD)
MCI Group
P-value
AD Group
P-valueFallers Non-fallers Fallers Non-fallers
(n=20) (n=18) (n=19) (n=18)
Age (years) 77.3 (6.2) 74.1 (6.5) 0.140 78.1 (6.1) 77.0 (6.2) 0.592
Female sex, n (%) 16 (80.0) 16 (88.9) 0.453 10 (52.6) 11 (61.1) 0.603
Body mass index (kg/m²) 28.6 (3.9) 30.6 (4.4) 0.155 27.6 (5.5) 27.2 (5.4) 0.828
Educational level (years) 4.5 (4.3) 5.7 (3.6) 0.337 5.8 (4.5) 5.2 (4.8) 0.715
Number of comorbidities 2.5 (1.2) 3.3 (1.5) 0.083 3.1 (1.3) 3.6 (1.0) 0.190
(continues)
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Over the 6-month follow-up, the time spent on both 
mobility tests was significant worse in fallers compared 
to non-fallers in the MCI Group. Moreover, the number 
of steps in the 10MWT was higher in fallers (p<0.05). 
In the AD Group, although there were no significant 
differences in TUG performance between fallers and 
non-fallers, the fallers were faster than non-fallers and 
the cadence was higher in fallers during the 10MWT 
performance (Table 2).
Table 3 shows the TUG and 10MWT variables that 
better discriminated fallers and non-fallers in each group. 
In the MCI Group, the best variable for discriminating 
fallers was the time spent on the 10MWT, with a cut-
off point greater or equal than 10.69 associated with 
the highest sensibility (80%) and accuracy (76.3%). 
A cut-off point of 13.78 in TUG performance had a 
65% sensibility, 72.2% specificity and 68.4% accuracy 
to predict falls. In the AD Group, the best variable for 
discriminating fallers was the cadence of the 10MWT, 
with a cut-off point ≥101.39 steps/minute associated with 
the highest specificity (88.9%) and accuracy (81.1%). A 
cut-off point of 17.56 seconds in TUG performance had 
a 78.9% sensibility, 61.1% specificity and 70.2% accuracy 
to predict falls.
Characteristics, M (SD)
MCI Group
P-value
AD Group
P-valueFallers Non-fallers Fallers Non-fallers
(n=20) (n=18) (n=19) (n=18)
Number of medication use 5.1 (2.8) 5.2 (3.8) 0.912 5.9 (4.1) 4.5 (1.9) 0.207
Psychotropic use, n (%) 8 (40.0) 6 (33.3) 0.671 17 (89.5) 12 (66.7) 0.092
Previous falls, n (%) 16 (80.0)** 6 (33.3) 0.004 12 (63.2) 9 (50.0) 0.419
Minnesota questionnaire 1200.0 (1694.2) 1863.3 (2415.5) 0.330 638.3 (834.4) 788.4 (1052.4) 0.633
**p<0.01; M(SD): mean (standard deviation); n (%): number of individuals (percentage); MCI: mild cognitive impairment; AD: Alzheimer’s disease; kg/m²: kilograms per meter squared.
Table 1. Continuation
Table 2. TUG and 10-meter walk tests performances between fallers and non-fallers identified over the 6-month follow-up
Variable, M (SD)
MCI Group
P-value
AD Group
P-valueFallers
Non-fallers (n=18)
Fallers
Non-fallers (n=18)
(n=20) (n=19)
TUG
Time (seconds) 16.0 (5.5)* 12.5 (2.2) 0.018 15.0 (4.5) 18.2 (5.1) 0.057
Number of steps 20.3 (6.1) 17.1 (3.5) 0.059 18.5 (4.9) 21.2 (6.5) 0.175
Cadence (steps/
min)
77.2 (8.5) 81.9 (10.1) 0.131 74.8 (9.1) 69.6 (8.0) 0.076
10MWT
Time (seconds) 13.6 (4.7)** 10.2 (1.7) 0.007 11.2 (3.1)* 13.6 (2.9) 0.021
Number of steps 22.3 (6.6)* 18.5 (3.9) 0.045 19.3 (3.9) 21.7 (4.5) 0.095
Cadence (steps/
min)
99.9 (12.8) 108.6 (15.4) 0.065 105.1 (12.7)** 95.4 (5.5) 0.005
*p<0.05; **p<0.01; M(SD): mean (standard deviation); n (%): number of individuals (percentage); MCI: Mild cognitive impairment; AD: Alzheimer’s disease; TUG: timed up and go test; 10MWT: 10-meter walk test.
Table 3. Cut-off points of TUG and 10-meter Walk tests for older people with MCI and AD
Groups Variable AUC(95% CI) P-value Cut-off point Sensibility Specificity Accuracy
Positive 
Likelihood ratio
Relative risk 
(95% CI)
MCI: Fallers vs. 
non-fallers
TUG
Time
0.70
(0.53-0.86)
0.039 ≥13.78 65.0% 72.2% 68.4% 2.34 2.06 
(1.06-4.00)
Steps - 0.072 - - - - - -
Cadence - 0.161 - - - - - -
10MWT
Time
0.77 
(0.61-0.93)
0.005 ≥10.69 80.0% 72.2% 76.3% 2.88
3.24 
(1.33-7.88)
Steps
0.71 
(0.54-0.87)
0.029 ≥18.50 70.0% 61.1% 65.8% 1.80
1.89 
(0.93-3.85)
Cadence - 0.054 - - - - - -
(continues)
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Table 4 shows the cross tabulation of older individuals 
who fell and who did not fall during a 6-month follow-up 
classified based on the TUG and the 10MWT cut-off 
points. In the MCI Group, considering 10.69 seconds 
as the best predictive value of the 10MWT, the positive 
predictive value was 76.19% and the negative predictive 
value was 76.47%. Regarding the AD Group, considering 
101.39 steps/minute as the best predictive value of the 
10MWT, the positive predictive value was 87.50% and 
the negative predictive value was 76.19%.
Table 4. Cross tabulation of fall risk assessment results using the 
timed up and go test and 10-meter walk test
MCI AD
Falls-Yes Falls-No   Falls-Yes Falls-No
TUG TUG
≥13.78 
seconds
13 5
≤17.56 
seconds
15 7
<13.78 
seconds
7 13 >17.56 
seconds
4 11
10MWT 10MWT
≥10.69 
seconds
16 5
≤12.31 
seconds
15 6
<10.69 
seconds
4 13
>12.31 
seconds
4 12
≥18.50 
steps
14 7
≥101.3 
steps/min
14 2
<18.50 
steps
6 11
<101.3 
steps/min
5 16
MCI: mild cognitive impairment; AD: Alzheimer disease; TUG: timed up and go; 10MWT: 10-meter 
walk test.
DISCUSSION
This study investigated which of the two commonly 
used functional mobility tools (TUG and 10MWT) 
best discriminated the risk of falls in older people with 
MCI and mild AD. The main findings of this study 
indicated that the time spent on the 10MWT was the 
most effective variable to differentiate fallers and non-
fallers in the MCI Group, while the variable that best 
discriminated fallers and non-fallers in the AD Group 
was the cadence of the 10MWT.
In this study, fallers showed higher prevalence of 
previous falls compared to non-fallers in the MCI 
Group, which corroborates the findings of Taylor et al.18 
Moreover, fallers with MCI were slower in both tests than 
non-fallers and they spent more steps in the 10MWT. 
In agreement with our results, the authors found that 
fallers with cognitive impairment were slower and had 
a shorter length step in the 4.6-meter walk test, which 
might be associated with number of steps, compared 
to non-fallers18. Mobility and balance disturbances in 
older people19,20, particularly with MCI21,22, could be 
associated with changes in the prefrontal cortex, which 
is responsible for executive functions and increases the 
risk for occurrence of falls. Thus, mobility tests could be 
used as assessment tools for those who either manifest or 
are at risk for developing cognitive impairment23.
In the AD Group, no differences at baseline were 
found between fallers and non-fallers. There are some 
divergences in the definition of fallers and non-fallers 
among studies10,18,21, which impairs the comparison with 
our findings. In this study, a faller was considered as a 
person who fell at least once during the follow-up, and 
both subgroups showed a high prevalence of previous falls. 
Also, fallers showed lower time and higher cadence in the 
10MWT performance than non-fallers. A higher grade of 
periventricular white matter lesions was identified among 
fallers compared to non-fallers in older people with mild 
to moderate AD, which may be related to cognition and 
postural balance24. Despite the high prevalence of falls, 
Table 3. Continuation
Groups Variable AUC(95% CI) P-value Cut-off point Sensibility Specificity Accuracy
Positive 
Likelihood ratio
Relative risk 
(95% CI)
AD: fallers vs.  
non-fallers
TUG
Time
0,70 
(0,53-0,87)
0,036 ≤17,56 78,90% 61,10% 70,20% 2,03 2,56 
(1,05-6,20)
Steps - 0,202 - - - - - -
Cadence - 0,06 - - - - - -
10MWT
Time
0,75 
(0,59-0,91)
0,009 ≤12,31 78,90% 66,70% 72,90% 2,37 2,86 
(1,17-6,96)
Steps - 0,098 - - - - - -
Cadence
0,79 
(0,62-0,95)
0,003 ≥101,39 73,70% 88,90% 81,10% 6,64 3,67 
(1,67-8,07)
95% CI: 95% confidence interval; AUC: area under the curve; MCI: mild cognitive impairment; AD: Alzheimer’s disease; TUG: timed up and go test; 10MWT: 10-meter walk test; p>0.05 (null hypothesis is accepted).
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older people with mild AD show less fear of falling than 
people with preserved cognition and MCI3. Therefore, a 
lack of perception of their own abilities and consciousness 
of their alterations may have influenced the 10MWT 
performance of fallers with AD, which might be related 
to less caution and protection strategies than non-fallers. 
Furthermore, a lower time in walk tests does not always 
mean a better mobility performance. As mechanisms 
related to falls may differ depending on the phase of AD, 
more studies are needed to compare mobility performance 
between fallers and non-fallers with mild AD.
In this study, the 10MWT was better than the TUG 
test in discriminating fallers and non-fallers with MCI 
and mild AD. Taylor et al.5 verified that fallers with 
cognitive impairment showed slower gait speed in simple 
gait than complex tasks conditions compared to non-
fallers5. Thus, the addition of a complex task provided no 
added benefit in discriminating fallers. In this context, our 
results may be explained since TUG is a more challenging 
test and it is composed by more subtasks (sit-to-stand, 
walking forward, turn, walking back and turn-to-sit)25. 
Thus, the 10MWT was the best test for discriminating 
fallers because the TUG test presented a higher degree 
of difficulty for both groups compared to 10MWT.
Additionally, the time spent on 10MWT was the best 
variable in distinguishing fallers with MCI, while the 
cadence of 10MWT better discriminated fallers with AD. 
Taylor et al.5 also concluded that the time spent on a walk 
test was able to discriminate fallers and non-fallers with 
cognitive impairment. However, these authors studied a 
heterogeneous group, without separating the different 
degrees of cognitive impairment. Regarding the AD 
Group, our results are in agreement with several authors 
who verified that cadence predicted the risk of falls in 
people with AD11,26,27. Alterations in cadence were related 
to frontal cognitive functions, particularly the executive 
function11. According to a systematic review27, memory 
and executive attention are associated with cadence and 
rhythm28, and these components are altered in people with 
AD29. Thus, the cadence is an important and a simple 
clinical measure to predicted falls in AD.
Although this study could determine which of the two 
functional mobility tools best discriminated risk of falls in 
a specific sample of older community people with MCI 
and mild AD, the authors recognize some limitations. 
The non-random sampling makes the generalization 
of our results unfeasible to Brazilian older adults. On 
the other hand, the authors worried about accurate falls 
data and distinguishing fallers and non-fallers in specific 
degrees of cognitive impairment. Knowing that the type 
of MCI and other classifications of fallers (sporadic and 
recurrent faller) might influence mobility performances 
and validation of the mobility tools studied for this 
population is scarce, new studies considering the above 
factors are needed to confirm our results.
In conclusion, the time and the cadence of 10MWT 
were the most accurate variables for screening the risk of 
falls among MCI Group and mild AD Group, respectively. 
The 10.69 second and the 101.39 steps/minute cut-off 
points seem to be the better predictive values for Brazilian 
older adults with MCI and mild AD, respectively. Besides, 
the 10MWT is a functional, simple and easy test, and, 
therefore, should be widely used in clinical practice.
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